The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries.
Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).
Financial Results:
Astec Lifesciences Ltd reported Revenues for Q3FY24 of ₹51.00 Crores down from ₹117.00 Crore year on year, a fall of 56.41%.
Total Expenses for Q3FY24 of ₹84.00 Crores down from ₹120.00 Crores year on year, a fall of 30.0%.
Consolidated Net Profit of -₹24.00 Crores from ₹1.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹12.41, from ₹0.43 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.